iRhythm Technologies Inc (NASDAQ:IRTC)
| 230.51 Delayed Data As of 3:59pm ET |  -7.86 / -3.30%Today’s Change | 56.24 Today|||52-Week Range 241.93 | +238.54% Year-to-Date |
Latest IRTC News | Press Releases
| Positions In The Portfolios Of The Best-Performing Small-Cap Growth Funds Sep 17 / Seeking Alpha - Paid Partner Content | iRhythm Technologies nabs UK funding for Zio trial Sep 08 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 238.37 |
| Today’s open | 237.26 |
| Day’s range | 227.07 - 238.92 |
| Volume | 10,257 |
| Average volume (3 months) | 388,000 |
| Market cap | $6.6B |
Data as of 3:59pm ET, 10/01/2020
Growth & Valuation
| Earnings growth (last year) | -6.85% |
| Earnings growth (this year) | +7.91% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +45.66% |
| P/E ratio | NM |
| Price/Sales | 8.02 |
| Price/Book | 43.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TNDMTandem Diabetes Care... | +0.11 | +0.10% |
| NVRONevro Corp | -0.16 | -0.11% |
| NVCRNovocure Ltd | +0.97 | +0.87% |
| LIVNLivaNova PLC | +0.81 | +1.79% |
Data as of 4:00pm ET, 10/01/2020
Financials
| Next reporting date | October 28, 2020 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | $214.6M |
| Annual profit (last year) | -$54.6M |
| Net profit margin | -25.43% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
